Anti-SMARCA2 / BRM antibody [EPR28611-92]
- RabMAb
- Recombinant
- 20ul selling size
- Advanced Validation
- What is this?
Be the first to review this product! Submit a review
|
(0 Publication)
Rabbit Recombinant Monoclonal SMARCA2 / BRM antibody. Suitable for WB, IP, ChIC/CUT&RUN-seq and reacts with Recombinant fragment - Human, Human samples.
View Alternative Names
BAF190B, BRM, SNF2A, SNF2L2, SMARCA2, SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 2, SAMRCA2, BRG1-associated factor 190B, Probable global transcription activator SNF2L2, Protein brahma homolog, SNF2-alpha, hBRM
- IP
Supplier Data
Immunoprecipitation - Anti-SMARCA2 / BRM antibody [EPR28611-92] (AB323179)
SMARCA2 / BRM was immunoprecipitated from 0.35 mg HeLa (human cervical adenocarcinoma epithelial cell) whole cell lysate with ab323179 at 1/30 dilution (2ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab323179 at 1000 dilution.
Blocking and dilution buffer and concentration : 5% NFDM/TBST
To minimize protein degradation, cells were lysed immediately after harvest and then applied for Immunoprecipitation as soon as possible.
All lanes:
Immunoprecipitation - Anti-SMARCA2 / BRM antibody [EPR28611-92] (ab323179) at 1/1000 dilution
Lane 1:
HeLa (human cervical adenocarcinoma epithelial cell) whole cell lysate at 10 µg
Lane 2:
ab323179 at 1/30 IP in HeLa (human cervical adenocarcinoma epithelial cell) whole cell lysate at 10 µg
Lane 3:
Rabbit monoclonal IgG (<a href='/en-us/products/primary-antibodies/rabbit-igg-monoclonal-epr25a-isotype-control-ab172730'>ab172730</a>) instead of ab323179 in HeLa whole cell lysate at 10 µg
Secondary
All lanes:
Immunoprecipitation - VeriBlot for IP Detection Reagent (HRP) (<a href='/en-us/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/5000 dilution
Observed band size: 200 kDa
false
Exposure time: 15s
- WB
Supplier Data
Western blot - Anti-SMARCA2 / BRM antibody [EPR28611-92] (AB323179)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
In lane 1, the lysate was stored at -80℃ prior to Western Blotting. The bands beneath the target band (200 kDa) are likely to be degradation products. In lane 2, To minimize protein degradation, cells were lysed immediately after harvest and then applied to a gel and transfer membrane for Western blotting as soon as possible.
In Western blot, Anti-Vinculin antibody [EPR8185] (ab129002) staining at 1/10000 dilution.
All lanes:
Western blot - Anti-SMARCA2 / BRM antibody [EPR28611-92] (ab323179) at 1/1000 dilution
All lanes:
HeLa (human cervical adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Observed band size: 200 kDa,124 kDa
false
Exposure time: 180s
- WB
Supplier Data
Western blot - Anti-SMARCA2 / BRM antibody [EPR28611-92] (AB323179)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
Low expression : SW-13, NCCIT (PMID : 16007216).
To minimize protein degradation, cells were lysed immediately after harvest and then applied to a gel and transfer membrane for Western blotting as soon as possible.
In Western blot, Anti-Vinculin antibody [EPR8185] (ab129002) staining at 1/10000 dilution.
All lanes:
Western blot - Anti-SMARCA2 / BRM antibody [EPR28611-92] (ab323179) at 1/1000 dilution
Lane 1:
K-562 (human chronic myelogenous leukemia lymphoblast) whole cell lysate at 50 µg
Lane 2:
HeLa (human cervical adenocarcinoma epithelial cell) whole cell lysate at 50 µg
Lane 3:
NCCIT (human pluripotent embryonic carcinoma epithelial cell) whole cell lysate at 50 µg
Lane 4:
SW-13 (human adrenal gland cortex epithelial cell) whole cell lysate at 50 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Observed band size: 200 kDa,124 kDa
false
Exposure time: 81s
- ChIC/CUT&RUN-seq
Supplier Data
ChIC/CUT&RUN sequencing - Anti-SMARCA2 / BRM antibody [EPR28611-92] (AB323179)
ChIC/CUT&RUN was performed using a pAG-MNase at a final concentration of 700 ng/mL, 2.5 x 105 HeLa (human cervix adenocarcinoma epithelial cell) cells and 5 µg of ab323179[EPR28611-92]. The resulting DNA was sequenced on the Illumina NovaSeq 6000 to a depth of 10 million reads. The negative IgG control ab172730 is also shown.
The University of Geneva owns patents relevant to ChIC (Chromatin Immuno-Cleavage) methods.
- ChIC/CUT&RUN-seq
Supplier Data
ChIC/CUT&RUN sequencing - Anti-SMARCA2 / BRM antibody [EPR28611-92] (AB323179)
ChIC/CUT&RUN was performed using a pAG-MNase at a final concentration of 700 ng/mL, 2.5 x 105 HeLa (human cervix adenocarcinoma epithelial cell) cells and 5 µg of ab323179[EPR28611-92]. The resulting DNA was sequenced on the Illumina NovaSeq 6000 to a depth of 10 million reads. The negative IgG control ab172730 is also shown.
The University of Geneva owns patents relevant to ChIC (Chromatin Immuno-Cleavage) methods.
- ChIC/CUT&RUN-seq
Supplier Data
ChIC/CUT&RUN sequencing - Anti-SMARCA2 / BRM antibody [EPR28611-92] (AB323179)
ChIC/CUT&RUN was performed using a pAG-MNase at a final concentration of 700 ng/mL, 2.5 x 105 HeLa (human cervix adenocarcinoma epithelial cell) cells and 5 µg of ab323179[EPR28611-92]. The resulting DNA was sequenced on the Illumina NovaSeq 6000 to a depth of 10 million reads. The negative IgG control ab172730 is also shown.
The University of Geneva owns patents relevant to ChIC (Chromatin Immuno-Cleavage) methods.
- WB
Supplier Data
Western blot - Anti-SMARCA2 / BRM antibody [EPR28611-92] (AB323179)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
This antibody does not cross-react with human BRG1.
In Western blot, Anti-6X His tag® antibody [EPR20547] - ChIP Grade (ab213204) staining at 1/5000 dilution.
All lanes:
Western blot - Anti-SMARCA2 / BRM antibody [EPR28611-92] (ab323179) at 1/1000 dilution
Lane 1:
His-tagged human SMARCA2/BRM fragment at 10 ng
Lane 2:
His-tagged human BRG1 fragment at 10 ng
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Observed band size: 28 kDa,36 kDa,20-36 kDa
false
Exposure time: 8s
Reactivity data
Product details
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com